Literature DB >> 1331326

Growth factor-like effects mediated by muscarinic receptors in PC12M1 cells.

R Pinkas-Kramarski1, R Stein, L Lindenboim, M Sokolovsky.   

Abstract

Rat pheochromocytoma (PC12) cells stably expressing cloned m1 muscarinic acetylcholine receptors (PC12M1) undergo morphological changes when stimulated by muscarinic agonists. These changes, which include the outgrowth of neurite-like processes, are blocked by the muscarinic antagonist atropine and are not observed in PC12 cells. The observed morphological changes, which are independent of RNA and protein synthesis, are blocked by the methylation inhibitor 5'-deoxy-5'-methylthioadenosine, suggesting that methylation plays a role in this process. Analysis of cyclic AMP accumulation and phosphoinositide turnover reveals that both processes are enhanced on activation by muscarinic agonist. Our data suggest, however, that the muscarinic-dependent neurite-like outgrowth processes are not mediated by cyclic AMP, Ca2+, or protein kinase C pathways. The muscarinic-dependent neurite outgrowth effect is enhanced by nerve growth factor, with a resulting increase in both the number of neurite-extending cells and the length of the neurite. In addition, activation of muscarinic receptors in PC12M1 cells stimulates the induction of marker genes for neuronal differentiation. Muscarinic receptors may therefore mediate growth factor-like effects in these cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331326     DOI: 10.1111/j.1471-4159.1992.tb10107.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  5 in total

1.  Coregulation of natively expressed pertussis toxin-sensitive muscarinic receptors with G-protein-activated potassium channels.

Authors:  Sinead M Clancy; Stephanie B Boyer; Paul A Slesinger
Journal:  J Neurosci       Date:  2007-06-13       Impact factor: 6.167

2.  Rho family GTPases and neuronal growth cone remodelling: relationship between increased complexity induced by Cdc42Hs, Rac1, and acetylcholine and collapse induced by RhoA and lysophosphatidic acid.

Authors:  R Kozma; S Sarner; S Ahmed; L Lim
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 3.  Potential role of muscarinic agonists in Alzheimer's disease.

Authors:  E E Avery; L D Baker; S Asthana
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

4.  Neuroprotective and Antioxidant Role of Oxotremorine-M, a Non-selective Muscarinic Acetylcholine Receptors Agonist, in a Cellular Model of Alzheimer Disease.

Authors:  Giuseppa Mudò; Valentina Di Liberto; Domenico Nuzzo; Monica Frinchi; Costanza Giardina; Miriana Scordino; Mariachiara Zuccarini; Chiara De Simone; Marta Di Carlo; Natale Belluardo
Journal:  Cell Mol Neurobiol       Date:  2022-09-03       Impact factor: 4.231

5.  The activation of M1 muscarinic receptor signaling induces neuronal differentiation in pyramidal hippocampal neurons.

Authors:  Kathryn L VanDeMark; Marina Guizzetti; Gennaro Giordano; Lucio G Costa
Journal:  J Pharmacol Exp Ther       Date:  2009-02-03       Impact factor: 4.030

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.